Donate For Public and Patients Store Search

S057 - Hot Topics

Monday, March 4; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss a variety of dermatologic 'hot topics' as identified by registrants at the annual meeting.
  • Recognize the medical/surgical implications of those entities, including diagnosis and treatment, especially emerging and innovative therapies.
  • Apply evolving evidence-based knowledge to patient care.

Description

The symposium will address those 'hot topics' established by registrant consensus, a true reflection of member concerns and interests. The somewhat unstructured session will be a 'potpourri' of medical/surgical topics, including some with social and economic import. Expert speakers will provide 'state of the art' material, highlighting recent trends and developments and accenting emerging and innovative therapies. Presentations will be derm relevant, clinically germane, and directly applicable to patient care

Disclosures

  • Baldwin, Hilary E., MD: Allergan, Inc. – A(H); Bayer – SP(NC); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – SP(H); Novan – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals International – SP(H);
  • Benedetto, Anthony V., DO: Allergan, Inc. – I(Fees), SH(ST), SP(H); Astellas Pharma US, Inc – SH(ST); BioDelivery Systems, Inc. – SH(SO); Bristol-Myers Squibb – SH(ST); Brothers Healthcare – B(NC); Castle Biosciences, Inc – A(H); DUSA Pharmaceuticals, Inc. – SP(H); Elan – SH(ST); Excaliard Pharmaceuticals, Inc. – C(H); Ipsen – SP(H); Johnson & Johnson Consumer Products Company – C(H); Liposonix – SP(H); Lumenis – SP(H); Merz Pharmaceuticals, LLC – C(H), SP(H); Osyris Medical USA – SP(H); sanofi-aventis – SH(ST); Shire – C(H); Stratapharma – C(H), I(H), SP(H);
  • Friedman, Adam J., MD: AbbVie – Speaker/Faculty Education(H); Aclaris Therapeutics Inc. – I(Grants/Research Funding); Allergan, Inc. – Speaker/Faculty Education(H); Amgen – A(H), Speaker/Faculty Education(H); Bayer – SP(H); Biogen – A(H); Dermira – C(H); Eli Lilly and Company – C(H); Encore Dermatology, Inc. – C(H); Exeltis – C(H); Galderma USA – C(H); Hoth Therapeutics – A(H); IntraDerm Pharmaceuticals – C(H); Janssen Biotech – SP(H), Speaker/Faculty Education(H); Johnson and Johnson Consumer Products Company – C(H); La Roche-Posay Laboratorie Pharmaceutique – A(H), C(H); Medscape – Speaker/Faculty Education(H); Menlo Therapeutics – A(H); Novartis – A(H); Oculus innovative Sciences, Inc. – C(H); Orlando Dermatology Aesthetic & Clinical (ODAC) – SP(H); Ortho Dermatologics – A(H); Pfizer Inc. – C(H); Promius Pharma, LLC – A(H), SP(H); Regeneron – Speaker/Faculty Education(H); Sanova Works – C(H); Valeant Pharmaceuticals International – I(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – A(H);
  • Guttman, Emma, MD, PhD: AbbVie – C(H), I(Grants/Research Funding); Almirall – A(H), C(H), I(Grants/Research Funding); Amgen – C(H), I(Grants/Research Funding); AnaptysBio – I(Grants/Research Funding); Asana Biosciences, LLC – A(H), C(H), I(Grants/Research Funding); Boehringer Ingelheim – A(H), C(H), I(Grants/Research Funding); Cara Therapeutics – A(H), C(H); Celgene Corporation – A(H), C(H), I(Grants/Research Funding); Concert Pharmaceuticals – C(H), I(Grants/Research Funding); DBV Technologies – A(H), C(H); Dermavant Sciences – A(H), I(Grants/Research Funding); Dermira – A(H), C(H), I(Grants/Research Funding); DS Biopharma – C(H), I(Grants/Research Funding); Eli Lilly and Company – A(H), C(H), I(Grants/Research Funding); EMD Serono – C(H); Escalier – A(H), C(H); FLX Bio – C(H); Galderma Research & Development, LLC – A(H), C(H), I(Grants/Research Funding); Glenmark Generics Inc. – A(H), C(H), I(Grants/Research Funding); Incyte Corporation – A(H); Innovaderm Research Inc. – I(Grants/Research Funding); Janssen Pharmaceuticals, Inc – I(Grants/Research Funding); Kiniksa Pharmaceuticals, Ltd. – I(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – A(H), C(H), I(Grants/Research Funding); Leo Pharma Inc – A(H), C(H), I(Grants/Research Funding); Mitsibushi Pharma – C(H); Novan – A(H), I(Grants/Research Funding); Novartis – A(H), C(H), I(Grants/Research Funding); Pfizer Inc. – A(H), C(H), I(Grants/Research Funding); Ralexar Therapeutics, Inc – I(Grants/Research Funding); Regeneron – A(H), C(H); Regeneron Pharmaceuticals, Inc. – I(Grants/Research Funding); Sanofi – A(H), C(H); Sienna Biopharmaceuticals – A(H), C(H), I(Grants/Research Funding); UCB – I(Grants/Research Funding); Union Therapeutics – C(H), I(Grants/Research Funding);
  • Jackson, J. Mark, MD: AbbVie – C(H), SP(H); Accuitis, Inc – C(Fees), C(SO); Aclaris Therapeutics Inc. – C(Fees); Beiersdorf, Inc. – C(H); Celgene Corporation – I(Grants/Research Funding); Dermira – C(H); Dr. Reddy – I(Grants/Research Funding); Encore Dermatology, Inc. – C(H); Foamix – C(H); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Janssen-Ortho Inc. – C(H), SP(H); Lilly ICOS LLC – C(H), SP(H); Menlo Therapeutics – C(H), I(Grants/Research Funding); Novartis – C(H), SP(H); Pfizer Inc. – C(H), I(Grants/Research Funding); Ralexar Therapeutics, Inc – C(Fees), C(SO); Regeneron Pharmaceuticals, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – C(H), SP(H); TopMD – A(SO);
  • Lebwohl, Mark, MD: AbbVie – I(Grants/Research Funding); Allergan, Inc. – C(H); Almirall – C(H); Amgen – I(Grants/Research Funding); Arcutis, Inc. – C(H); AstraZeneca – I(Grants/Research Funding); Avotres, Inc. – C(H); BirchBioMed – C(H); Boehringer Ingelheim – C(H), I(Grants/Research Funding); Bristol-Myers Squibb – C(H); Cara Therapeutics – C(H); Castle Biosciences, Inc – C(H); Celgene Corporation – I(Grants/Research Funding); Clinuvel – I(Grants/Research Funding); Corrona, Inc. – O(H); Dermavant Sciences – C(H); Dr. Reddy – C(H); Eli Lilly and Company – I(Grants/Research Funding); Foundation for Research & Education of Dermatology – O(H); Incyte Corporation – I(Grants/Research Funding); Inozyme Pharma – C(H); Janssen Research & Development, LLC – I(Grants/Research Funding); Kadmon Corporation, LLC – I(Grants/Research Funding); Leo Pharma Inc – C(H); LEO Pharma, US – I(Grants/Research Funding); Medimmune – I(Grants/Research Funding); Meiji Seika Pharma Co., Ltd – C(H); Menlo Therapeutics – C(H); Mitsibushi Pharma – C(H); Neuroderm LTD – C(H); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Ortho Dermatologics – I(Grants/Research Funding); Pfizer Inc. – C(H), I(Grants/Research Funding); SCIderm – I(Grants/Research Funding); Theravance Biopharma – C(H); UCB – I(Grants/Research Funding); Verrica Pharmaceuticals Inc – C(H); Vidac Pharma – I(Grants/Research Funding);
  • Mesinkovska, Natasha Atanaskova, MD, PhD: BiologicsMD, Inc. – C(H);
  • Rigel, Darrell S., MD: Aclaris Therapeutics, Inc. – C(H); Beiersdorf, Inc. – A(H); Castle Biosciences – A(H), I(Grants/Research Funding); Derm Tech International – A(H), C(H); Ferndale Laboratories, Inc. – C(H); Foamix – SH(SO); LEO Pharma, US – A(H); Myriad Genetics Inc – A(H); Novartis – A(H); Ortho Dermatologics – A(H); Pierre Fabre Dermo-Cosmétique US – A(H); SciBASE – C(H);
  • Tomecki, Kenneth J., MD: no financial relationships exist with commercial interests.
Schedule
Monday, March 4
1:00 PM
Dr. Tomecki / Introduction
1:02 PM
Dr. Baldwin / Acne: What's New?
1:24 PM
Dr. Lebwohl / Biologics and Psoriasis: The Beat Goes On
1:46 PM
Guttman-Yassky / Atopic Dermatitis: New Developments
2:08 PM
Dr. Jackson / Drug Eruptions: The Good, Bad, and Ugly
2:30 PM
Dr. Rigel / Melanoma Update 2019
2:52 PM
Dr. Mesinkovska / Hairy Matters: What's New in Alopecia?
3:14 PM
Dr. Friedman / Cosmeceuticals: Naturally Absurd?
3:36 PM
Dr. Benedetto / What's New in Cosmetic Surgery?
Event Details
  • Date
    Monday, March 4
  • Time
    1:00 PM - 4:00 PM
  • Location
    Ballroom C
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
  • Kenneth J. Tomecki, MD, FAAD
Speakers
  • Adam J. Friedman, MD, FAAD - Handout
  • Anthony V. Benedetto, DO, FAAD
  • Darrell S. Rigel, MD, FAAD
  • Emma Guttman, MD, PhD, FAAD - Handout
  • Hilary E. Baldwin, MD, FAAD
  • J. Mark Jackson, MD, FAAD
  • Mark Lebwohl, MD, FAAD - Handout
  • Natasha Atanaskova Mesinkovska, MD, PhD, FAAD